EcoCeres supports AstraZeneca’s journey to net zero with its 1st HVO application in China’s pharmaceutical sector
EcoCeres announced Sept. 24 a partnership to supply hydrotreated vegetable oil (HVO), also known as renewable diesel, to AstraZeneca for use at its medicines manufacturing facility in Wuxi, Jiangsu Province, China.
The renewable fuel, verified by the International Sustainability and Carbon Certification System GmbH, is produced from used cooking oil (UCO) and will support backup-power generation at the site.
Using this fuel can cut lifecycle greenhouse-gas emissions by up to 90 percent compared with conventional diesel.
By replacing conventional fossil-based diesel in AstraZeneca’s backup-generator system, EcoCeres HVO supports the site’s decarbonization while maintaining the reliability required for critical medicines manufacturing activities.
The collaboration demonstrates how certified renewable fuels can provide a practical decarbonization solution for industrial operations.
“We are proud to partner with AstraZeneca on this pioneering project, which demonstrates the versatility and scalability of HVO as a drop-in renewable fuel solution,” said EcoCeres CEO Matti Lievonen. “This collaboration not only highlights the role of advanced biofuels in decarbonizing power generation but also sets a new benchmark for sustainable operations in China’s pharmaceutical industry.”
Ewa Maqdosi, the vice president of AstraZeneca’s Wuxi manufacturing site, added, “We are pleased to collaborate with EcoCeres to advance innovative solutions that support more sustainable and resilient operations. By integrating renewable fuels into our operations, we are reducing greenhouse-gas emissions while maintaining the operational resilience that is essential to our manufacturing activities. This initiative reflects our commitment to delivering on AstraZeneca’s ‘Ambition Zero Carbon’ strategy and goal to reduce our scopes 1 and 2 emissions across the company by 98 percent by the end of 2026.”
EcoCeres said the collaboration reflects its commitment to expanding practical, scalable renewable fuel solutions across China’s industrial sector.
It also supports AstraZeneca’s ongoing efforts to reduce emissions across its operations through innovative energy and decarbonization initiatives.
